Labcorp.

Company Overview

LabCorp. operates across both the clinical and research areas of life sciences. LabCorp Diagnostics offers routine and specialized testing services to hospitals and healthcare networks. Similarly, LabCorp Drug Development (formerly Covance) supports pharmaceutical and biotech companies through preclinical research, clinical trials, and post-approval studies.

LabCorp. supports drug development programs with a wide range of nonclinical studies, including safety pharmacology, toxicology, bioanalysis, and the regulatory documentation required for submissions. Its scientific and laboratory network enables work from early discovery through late-stage development, covering in-vitro and in vivo safety assessments, method development, and the generation of regulated data.

LabCorp. supports in vitro toxicology with assays that probe cytotoxicity, genotoxicity, and organ-focused effects, along with other mechanistic signs of risk. The studies utilize cell models, molecular approaches, and high-throughput screening to clarify how new chemical or biological candidates may behave before advancing in development.

Financial Highlights (FY 2025)

Company's Business Segments

• Diagnostics Laboratories (Dx) : Diagnostics Laboratories (Dx), which includes routine testing and specialty/esoteric testing
• Biopharma Laboratory Services (BLS) : Biopharma Laboratory Services (BLS), consisting of Early Development Research Laboratories and Central Laboratory Services